Detection of preQ0 deazaguanine modifications in bacteriophage CAjan DNA using Nanopore sequencing reveals same hypermodification at two distinct DNA motifs.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
09 10 2020
Historique:
accepted: 26 08 2020
revised: 19 08 2020
received: 18 03 2020
pubmed: 18 9 2020
medline: 5 11 2020
entrez: 17 9 2020
Statut: ppublish

Résumé

In the constant evolutionary battle against mobile genetic elements (MGEs), bacteria have developed several defense mechanisms, some of which target the incoming, foreign nucleic acids e.g. restriction-modification (R-M) or CRISPR-Cas systems. Some of these MGEs, including bacteriophages, have in turn evolved different strategies to evade these hurdles. It was recently shown that the siphophage CAjan and 180 other viruses use 7-deazaguanine modifications in their DNA to evade bacterial R-M systems. Among others, phage CAjan genome contains a gene coding for a DNA-modifying homolog of a tRNA-deazapurine modification enzyme, together with four 7-cyano-7-deazaguanine synthesis genes. Using the CRISPR-Cas9 genome editing tool combined with the Nanopore Sequencing (ONT) we showed that the 7-deazaguanine modification in the CAjan genome is dependent on phage-encoded genes. The modification is also site-specific and is found mainly in two separate DNA sequence contexts: GA and GGC. Homology modeling of the modifying enzyme DpdA provides insight into its probable DNA binding surface and general mode of DNA recognition.

Identifiants

pubmed: 32941607
pii: 5907968
doi: 10.1093/nar/gkaa735
pmc: PMC7544227
doi:

Substances chimiques

7-(aminomethyl)-7-deazaguanine 0
DNA Restriction-Modification Enzymes 0
Pyrimidinones 0
Pyrroles 0
Guanine 5Z93L87A1R
DNA 9007-49-2
7-deazaguanine GPL8T5ZO3M

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10383-10396

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM110588
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

J Mol Biol. 2002 May 3;318(3):665-77
pubmed: 12054814
Genome Announc. 2015 Jul 16;3(4):
pubmed: 26184932
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1452-9
pubmed: 26929322
Nat Rev Microbiol. 2013 Oct;11(10):675-87
pubmed: 23979432
Gigascience. 2018 Apr 1;7(4):
pubmed: 29617771
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W369-73
pubmed: 16845028
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Curr Opin Microbiol. 2005 Aug;8(4):466-72
pubmed: 15979932
Biomolecules. 2017 Feb 08;7(1):
pubmed: 28208705
PLoS One. 2019 May 16;14(5):e0216709
pubmed: 31095620
Nat Struct Mol Biol. 2004 Aug;11(8):714-20
pubmed: 15221026
Nat Struct Biol. 2003 Oct;10(10):781-8
pubmed: 12949492
Genome Biol. 2018 Jul 13;19(1):90
pubmed: 30005597
Arch Virol. 2016 Aug;161(8):2219-26
pubmed: 27231007
Nature. 1952 Dec 20;170(4338):1072-3
pubmed: 13013321
mBio. 2015 Jun 16;6(3):e00648
pubmed: 26081634
Nat Rev Microbiol. 2005 Jun;3(6):504-10
pubmed: 15886693
RNA Biol. 2017 Sep 2;14(9):1175-1184
pubmed: 27937735
Nat Methods. 2017 Apr;14(4):411-413
pubmed: 28218897
Nat Commun. 2019 Jun 4;10(1):2449
pubmed: 31164644
Nat Commun. 2019 Nov 29;10(1):5442
pubmed: 31784519
Nat Rev Genet. 2014 Oct;15(10):647-61
pubmed: 25159599
PLoS Comput Biol. 2013;9(3):e1002935
pubmed: 23516341
J Mol Biol. 2016 Feb 22;428(4):720-725
pubmed: 26410586
ACS Synth Biol. 2017 Jul 21;6(7):1351-1358
pubmed: 28324650
Mutat Res. 2000 Aug 30;460(3-4):211-29
pubmed: 10946230
F1000Res. 2015 Oct 15;4:1075
pubmed: 26834992
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2172-5
pubmed: 2648393
Cell. 1998 Oct 16;95(2):249-58
pubmed: 9790531
Nat Rev Microbiol. 2010 May;8(5):317-27
pubmed: 20348932
Annu Rev Microbiol. 1980;34:137-58
pubmed: 7002022
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495

Auteurs

Witold Kot (W)

Department of Plant and Environmental Science, University of Copenhagen, Denmark.

Nikoline S Olsen (NS)

Department of Environmental Science, Aarhus University, Roskilde, Denmark.

Tue K Nielsen (TK)

Department of Plant and Environmental Science, University of Copenhagen, Denmark.

Geoffrey Hutinet (G)

Department of Microbiology and Cell Science, University of Florida, Gainesville, FL USA.

Valérie de Crécy-Lagard (V)

Department of Microbiology and Cell Science, University of Florida, Gainesville, FL USA.
Genetics Institute, University of Florida, Gainesville, FL, USA.

Liang Cui (L)

Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore.

Peter C Dedon (PC)

Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore.
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.

Alexander B Carstens (AB)

Department of Plant and Environmental Science, University of Copenhagen, Denmark.

Sylvain Moineau (S)

Département de biochimie, de microbiologie et de bio-informatique, Université Laval, Québec City, PQ, Canada.
Groupe de recherche en écologie buccale, Faculté de médecine dentaire, Université Laval, Québec City, PQ, Canada.
Félix d'Hérelle Reference Center for Bacterial Viruses, Université Laval, Québec City, PQ, Canada.

Manal A Swairjo (MA)

Department of Chemistry and Biochemistry and the Viral Information Institute, San Diego State University, San Diego, CA, USA.

Lars H Hansen (LH)

Department of Plant and Environmental Science, University of Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH